At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illuminaの外部リンク
BaseSpace Clarity LIMS is a laboratory information management system that helps genomics labs track samples and manage workflows for an optimized and efficient lab.
This weekend, Illumina was proud to join the San Diego Pride Parade 2024. 🌈 We take pride in having diversity and inclusion as part of our DNA and in fostering a work environment where our employees can thrive and be their true selves. A special shout-out to iPride, one of our employee resource groups, for organizing our participation and promoting pride throughout the year. #SDPride #Pride2024 #DEI
Next-generation sequencing is more accessible than ever, helping researchers drive more discovery power at a lower cost. New to #NGS? There has never been a better time to start: https://bit.ly/4dUGGhJ
Acutely ill infants with a suspected genetic disease may have a critical window to receive a diagnosis and care. That’s why University of Utah Health and ARUP Labs are working together to offer rWGS as a first-tier test in the NICU. https://bit.ly/3zPvtPX
In Australia, Victorian Clinical Genetics Services (VCGS) is conducting research to study the use of genome #sequencing for critically ill children. Their new study screens 1,000 newborns, aiming for early identification of over 600 treatable childhood-onset conditions under a research protocol. Discover how VCGS is relying on Emedgene software to scale this project: https://bit.ly/3SfC7W5 #newbornscreening
We’re proud to have earned a top score on the Disability Equality Index and be recognized as a Best Place to Work for Disability Inclusion for a third consecutive year by Disability:IN and the American Association of People with Disabilities. Disability inclusion is core to fostering diversity, equity, and belonging in everything we do. https://bit.ly/467shve #IlluminaProud
Illuminaさんが再投稿しました
The second annual Illumina Scholars in STEM high school program is off to an incredible start after week one! Illumina partnered with nonprofit organizations SD2 and Junior Achievement to create a two-week program aimed at enhancing students' professional skills and introducing them to various career paths in biotech. Highlights included: 🌟 Meeting 29 passionate and driven students eager to make an impact and develop skills for their future careers 🌟 Guiding students to discover and embrace their unique strengths 🌟 Sireesha Lujan providing insights into the world of genomics and its impact in healthcare 🌟 Christina Hastings emphasizing the importance of communication, which helped students build confidence and learn how to enrich conversations 🌟 Katie Carlseen Tracie Rosado Erica Linn Vanessa Light joining students for a gratitude-themed hike at Torrey Pines We are THRILLED to welcome the students to Illumina this upcoming week, with 70 volunteers excited to meet them! #CSR #giveback #illumina #purpose Karmin Noar Pana Hap Hanna Jensen H. Puentes Sharon Vidal Nicole Zuniga Loren Korch
Today Illumina is acquiring Fluent BioSciences Inc. to accelerate the adoption of single-cell analysis and help customers with the broadest range of project sizes. On our mission to unlock the power of the genome to improve human health, we see this as a step to enable faster discovery. Learn more: https://bit.ly/3XYQdPk
Since its founding in 2022, iHope China has supported over 500 families with rare genetic diseases by providing free genetic testing and offering systematic training to front-line clinicians. By the end of 2024, the program aims to broaden its reach and impact—supporting 1,800 families with genetic testing. #Genomics4All #IlluminaProud Learn more about how the Illumina iHope China program is making strides to more than triple their impact: https://bit.ly/3VXa8Nb.